Načítá se...
Relative Tolerability of Alzheimer's Disease Treatments
OBJECTIVE: In the US, approved therapies for mild to moderate Alzheimer's disease (AD) currently comprise three cholinesterase inhibitors (ChEIS: donepezil, galantamine, and rivastigmine), while the N-methyl-D-aspartate (NMDA) receptor antagonist memantine and the ChEI donepezil are approved fo...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Matrix Medical Communications
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2695725/ https://ncbi.nlm.nih.gov/pubmed/19724715 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|